Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) drew a synopsis of meaningful financial and research achievements in its annual report for the fiscal year 2023 ending Aug. 31, culminating in an agreement to be acquired by Exopharm Limited, an Australian Securities Exchange-listed company. Throughout 2023, the biotechnology company, which focuses on …

New York City‘s first legal adult-use dispensary, Housing Works Cannabis Co. logged $24 million in sales in its first year of business. That’s a significant portion of the $137 million in sales that the New York Cannabis Control Board reported for the entire state as of early December, according to …

Yet another turbulent but victory-filled 12 months for many in the cannabis trade is behind us, and plenty of business leaders are ready to focus on 2024. “The forthcoming year will be the most exciting ever in the industry,” said Morgan Paxhia, co-founder and managing director of Poseidon Investment Management. …

The U.S. Drug Enforcement Administration put Georgia pharmacies on notice that they could be targets for federal enforcement if they engage in medical cannabis commerce. That could have a chilling effect on the nascent southern marijuana market. On Nov. 27, the DEA’s Diversion Control Division sent a notice to many …